Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, WHO Pathogens Priority List Working Group (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18:318–327. https://doi.org/10.1016/S1473-3099(17)30753-3
Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:657–686. https://doi.org/10.1128/CMR.18.4.657-686.2005
Article PubMed PubMed Central CAS Google Scholar
Ra B, Em B, Bm JC, L L, Ja P, Lf S W (2018) Carbapenemase-Producing organisms: A global scourge. Clin Infect Dis Off Publ Infect Dis Soc Am 66. https://doi.org/10.1093/cid/cix893
Comité (2024) de l’Antibiogramme de la Société Française de Microbiologie Recommandations 2024
Noubam-Tchatat CC, Maurin E, Proust S, Beyrouthy R, Bonnet R, Robin F (2024) MAST® D72C test: a novel option for ESBL, AmpC and carbapenemase detection. Eur J Clin Microbiol Infect Dis 43:1181–1192. https://doi.org/10.1007/s10096-024-04829-4
Article PubMed CAS Google Scholar
Gröndahl-Yli-Hannuksela K, Lönnqvist E, Marttila H, Rintala E, Rantakokko-Jalava K, Vuopio J (2020) Performance of the Check-Direct ESBL screen for BD MAXTM for detection of asymptomatic faecal carriage of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae. J Glob Antimicrob Resist 22:408–413. https://doi.org/10.1016/j.jgar.2020.04.015
Nurjadi D, Chalin A, Hauswaldt S, Olson L, Larsson M, Östholm Å, Velavan TP, Boutin S, Rupp J, Nilsson LE, Hanberger H (2024) A proof-of-principle study for the point-of-care detection of ESBL (CTX-M) by NG-Test® CTX-M MULTI lateral flow assay in urine samples using a simplified method for use in a resource-limited setting. JAC-Antimicrob Resist 6:dlae103. https://doi.org/10.1093/jacamr/dlae103
Article PubMed PubMed Central Google Scholar
Stürenburg E, Lang M, Horstkotte MA, Laufs R, Mack D (2004) Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum β-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria. J Antimicrob Chemother 54:870–875. https://doi.org/10.1093/jac/dkh449
Article PubMed CAS Google Scholar
Robin F, Delmas J, Schweitzer C, Bonnet R (2008) Evaluation of the Vitek-2 extended-spectrum beta-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 14:148–154. https://doi.org/10.1111/j.1469-0691.2007.01893.x
Berinson B, Both A, Berneking L, Christner M, Lütgehetmann M, Aepfelbacher M, Rohde H (2021) Usefulness of biofire filmarray BCID2 for blood culture processing in clinical practice. J Clin Microbiol 59:e0054321. https://doi.org/10.1128/JCM.00543-21
Gonzalez C, Oueslati S, Biez L, Dortet L, Naas T (2022) Evaluation of the EasyScreen™ ESBL/CPO detection kit for the detection of ß-Lactam resistance genes. Diagn Basel Switz 12:2223. https://doi.org/10.3390/diagnostics12092223
Renvoisé A, Decré D, Amarsy-Guerle R, Huang T-D, Jost C, Podglajen I, Raskine L, Genel N, Bogaerts P, Jarlier V, Arlet G (2013) Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae. J Clin Microbiol 51:4012–4017. https://doi.org/10.1128/JCM.01936-13
Article PubMed PubMed Central CAS Google Scholar
Kawamoto Y, Kosai K, Yamakawa H, Kaku N, Uno N, Morinaga Y, Hasegawa H, Yanagihara K (2019) Detection of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae using the MALDI biotyper selective testing of antibiotic resistance-β-lactamase (MBT STAR-BL) assay. J Microbiol Methods 160:154–156. https://doi.org/10.1016/j.mimet.2019.03.019
Article PubMed CAS Google Scholar
Bianco G, Boattini M, Iannaccone M, Cavallo R, Costa C (2020) Evaluation of the NG-test CTX-M MULTI immunochromatographic assay for the rapid detection of CTX-M extended-spectrum-β-lactamase producers from positive blood cultures. J Hosp Infect 105:341–343. https://doi.org/10.1016/j.jhin.2020.02.009
Article PubMed CAS Google Scholar
Gonzalez C, Moguet C, Chalin A, Oueslati S, Dortet L, Simon S, Volland H, Naas T (2022) Comparison of three Expanded-Spectrum cephalosporin hydrolysis assays and the NG-Test CTX-M multi assay that detects all CTX-M-Like enzymes. Diagn Basel Switz 12:197. https://doi.org/10.3390/diagnostics12010197
Bernabeu S, Ratnam KC, Boutal H, Gonzalez C, Vogel A, Devilliers K, Plaisance M, Oueslati S, Malhotra-Kumar S, Dortet L, Fortineau N, Simon S, Volland H, Naas T (2020) A lateral flow immunoassay for the rapid identification of CTX-M-Producing Enterobacterales from culture plates and positive blood cultures. Diagn Basel Switz 10:764. https://doi.org/10.3390/diagnostics10100764
Zamudio R, Boerlin P, Beyrouthy R, Madec J-Y, Schwarz S, Mulvey MR, Zhanel GG, Cormier A, Chalmers G, Bonnet R, Haenni M, Eichhorn I, Kaspar H, Garcia-Fierro R, Wood JLN, Mather AE (2022) Dynamics of extended-spectrum cephalosporin resistance genes in Escherichia coli from Europe and North America. Nat Commun 13:7490. https://doi.org/10.1038/s41467-022-34970-7
Article PubMed PubMed Central CAS Google Scholar
EUCAST subcommittee for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance (2017) EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. https://www.eucast.org/resistance_mechanisms. Accessed 3 Aug 2023
Kamijo T, Horiuchi K, Negishi T, Natori T, Yamane T, Hachiro A, Uehara T, Hayashi W, Nagano N (2024) First detection of chimeric β-lactamase CTX-M-64-producing Salmonella typhimurium from a domestic source in Japan. Jpn J Infect Dis 77:47–50. https://doi.org/10.7883/yoken.JJID.2023.163
Article PubMed CAS Google Scholar
de la Ortiz JM, Demord A, Poirel L, Greub G, Blanc D, Nordmann P (2021) False immunological detection of CTX-M enzymes in Klebsiella Oxytoca. J Clin Microbiol 59:e00609–e00621. https://doi.org/10.1128/JCM.00609-21
de la Ortiz JM, Bouvier M, Poirel L, Greub G, Blanc D, Nordmann P (2022) Cross-reaction of naturally-produced β-lactamases from Citrobacter Farmeri and Citrobacter amalonaticus with immunological detection of CTX-M enzymes. Diagn Microbiol Infect Dis 104:115760. https://doi.org/10.1016/j.diagmicrobio.2022.115760
Robin F, Beyrouthy R, Bonacorsi S, Aissa N, Bret L, Brieu N, Cattoir V, Chapuis A, Chardon H, Degand N, Doucet-Populaire F, Dubois V, Fortineau N, Grillon A, Lanotte P, Leyssene D, Patry I, Podglajen I, Recule C, Ros A, Colomb-Cotinat M, Ponties V, Ploy MC, Bonnet R (2017) Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as assessed by a multicenter study. Antimicrob Agents Chemother 61:e01911–e01916. https://doi.org/10.1128/AAC.01911-16
Article PubMed PubMed Central CAS Google Scholar
Bevan ER, Jones AM, Hawkey PM (2017) Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother 72:2145–2155. https://doi.org/10.1093/jac/dkx146
Article PubMed CAS Google Scholar
Pereira JL, Volcão LM, Klafke GB, Vieira RS, Gonçalves CV, Ramis IB, da Silva PEA, von Groll A (2019) Antimicrobial resistance and molecular characterization of extended-spectrum β-lactamases of Escherichia coli and Klebsiella spp. isolates from urinary tract infections in Southern Brazil. Microb Drug Resist 25:173–181. https://doi.org/10.1089/mdr.2018.0046
Article PubMed PubMed Central CAS Google Scholar
Yang J-H, Sheng W-H, Hsueh P-R (2020) Antimicrobial susceptibility and distribution of extended-spectrum β-lactamases, AmpC β-lactamases and carbapenemases among Proteus, Providencia and Morganella isolated from global hospitalised patients with intra-abdominal and urinary tract infections: results of the study for monitoring antimicrobial resistance trends (SMART), 2008–2011. J Glob Antimicrob Resist 22:398–407. https://doi.org/10.1016/j.jgar.2020.04.011
Comments (0)